Trial Library Welcomes Craig L. Tendler, M.D. as a Clinical and Scientific Advisor

Join us in welcoming Craig L. Tendler, M.D. to Trial Library as an advisor. Dr. Tendler brings over 30 years of pharmaceutical development expertise, with a distinguished career most recently as Vice President of Oncology Clinical Development and Global Medical Affairs at Janssen Research & Development (Johnson & Johnson).

Throughout his career, Dr. Tendler has been instrumental in bringing over 30 major drug approvals to patients worldwide, including at least 10 FDA-approved therapies. His leadership in clinical development strategy, regulatory affairs, and medical governance has transformed treatment landscapes in oncology and other therapeutic areas.

At Johnson & Johnson Innovative Medicine, Dr. Tendler led comprehensive development plans and data generation activities across the oncology portfolio, from late-stage development through registration and lifecycle management. His teams secured multiple FDA breakthrough therapy designations and expedited global approvals for treatments in prostate cancer, hematologic malignancies, and bladder cancer.

Reflecting on joining Trial Library, Dr. Tendler shared: "As a previous oncology sponsor who benefitted from Trial Library's AI-enabled platform to make our trials more accessible to potentially eligible patients, I am delighted to further enhance their efforts to accelerate oncology drug development for the benefit of patients."

Dr. Tendler's expertise in addressing unmet medical needs and implementing science-driven clinical research strategies aligns perfectly with Trial Library's mission to improve diverse representation in clinical trials and expand access to potentially life-saving treatments.